Prevalence, Characters and Determinants of Irritable Bowel Syndrome

Aims: To generate reliable estimates of the prevalence of IBS by age, sex and
symptom group in Thiqar Governorate in APRIL 2022. Justification: Due to
the high prevalence of Irritable Bowel Syndrome and between early ages, I
thought that I would conduct this research to find out the reason for its spread .
Method: This is an cross sectional analytical study to determine the prevalence
of irritable bowel syndrome. Results: Independent sample t-test Table2
comparison of classical symptoms of IBS between males and females. 245
females suffer from nausea and 23 males, there is a statistically significant
difference between males and females p=0.009. Also, 171 males have
constipation, and 23, there is a statistically significant difference between males
and females p=0.001. on the other hand, there is no statistically significant
difference between males and females in other symptoms. demographic and
clinical data for 595 participants. The mean age was 27.28 (±9.53), with height
and weight 159.78 (±14.94) and 65.62 (±15.62) respectively. The majority of
study participants were females 522 (83.9%), and only 73 (11.7%) were males.
Around one-half have an average income 307 (49.4%). 390 (62.7%) were
single. 569 (91.5%) was a non-smoker. 261 (42.0%) were working, while 243
(39.1%) students. In this study, the blood group observed was O blood group
229 (36.8%). 344 (55.3%) have irritable bowel syndrome and 531 (85.4%) don’t
have any chronic disease. symptoms of IBS. 280 (45.0%) state that flatulence is
related to eating. Also, 222 (35.7%) and 195 (31.4%) had shortness of breath
and felt incompatible bowel movements respectively. The most frequent
location of IBS pain in this study was at the right of the abdomen 229 (38.4%).
Around one-half have bloating 305 (49.0%). Most of them do not have pain 222
(37.3%). Conclusion: IBS is a complex disorder with a pathophysiology that is
poorly understood. symptoms according to the limited evidence-based medicine
supporting specific agents in the treatment of IBS symptomatology. The
monitoring, education, and support of patients that doctors provides renders
their role vital in IBS management.